Michael Cloonan

Insider Reports History

Entity
Individual
Location
C/O Sage Therapeutics, Inc., 215 First Street, Cambridge, MA
Signature
/s/ Sydney Gaylin, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Cloonan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
bluebird bio, Inc. Director Common Stock 37.4K $19.6K $0.53 Sep 30, 2024 Direct
bluebird bio, Inc. Director Stock Option (right to buy) 74.8K Jun 20, 2024 Direct

Insider Reports Filed by Michael Cloonan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BLUE bluebird bio, Inc. Sep 30, 2024 1 $0 4 Oct 2, 2024 Director
BLUE bluebird bio, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
BLUE bluebird bio, Inc. Jun 20, 2024 0 $0 3 Jun 24, 2024 Director